- Scrip Originals
Brought to you by
Novartis buys CoStim Pharmaceuticals
18 Sep 2020
Novartis AG acquired CoStim Phamaceuticals Inc., a closely held firm that has been working on immune-based cancer therapeutics.
- Acquisition of Private Biotech
- Full Acquisition
Already a Biomedtracker subscriber? You have access to the full deal record through your subscription
Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com